Navigation Links
FASEB SRC announces conference registration open for: Hematologic Malignancies
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Hematologic Malignancies.

The 2013 FASEB conference on Hematologic Malignancies is an important and unique scientific conference where basic and translational research on leukemias, lymphomas, and myeloma is presented in detail in the premier meeting in the field. The underlying theme for the 2013 conference is "Genomics and Targeted Therapy". This meeting includes outstanding researchers from around the world presenting cutting edge research directed towards genomic profiling of hematologic malignancies, mechanistic studies into hematopoietic transformation, and the development of novel, molecularly targeted therapies for patients with hematologic neoplasms.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford, CMP
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
2. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
3. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
4. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
5. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
6. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
7. FASEB urges biomedical research community to speak out against sequestration
8. FASEB lauds Air India for transporting research animals
9. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
10. FASEB 2013 Excellence in Science Award recipient announced
11. Elsevier announces the launch of a new journal: Anthropocene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016  Regular discussions on a range of subjects including ... two entities said Poloz. Speaking at a lecture ... , he pointed to the country,s inflation target, which is ... "In certain areas there ... common economic goals, why not sit down and address strategy ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology: